2025. Abnormal Expression of WSB1 in Lung Adenocarcinoma: A Potential Prognostic and Immunotherapeutic Sensitivity Biomarker. Advances in World Medical Research. 1, 2 (Dec. 2025), 48–63. DOI:https://doi.org/10.71204/1bcv8650.